Science Explorer Back to mapMap
Discussion
Researcher · Instituto de Hematología e Inmunología · Cuba

René Rivero Jiménez

René Rivero Jiménez publishes mostly in Genetics, Hematology and Public Health, Environmental and Occupational Health, on topics such as Chronic Lymphocytic Leukemia Research, Acute Myeloid Leukemia Research and Hemoglobinopathies and Related Disorders.

OpenAlex
World rank
#7,397,610
of 7,710,434 ranked researchers
Rank in Cuba
#6,134
of 7,334
Works
32
Citations
24
Citations per work
0.8
h-index
3
i10-index 0Top 96% in Genetics (Medicine)
René Rivero Jiménez

What does René Rivero Jiménez research?

René Rivero Jiménez's work is mostly in Medicine (61%), Engineering (6%), Business, Management and Accounting (6%).

Health Sciences: 20 works · 61.3% of their workMedicine: 20 works · 61.3% of their workGenetics: 8 works · 25.4% of their workHematology: 8 works · 23.9% of their workPublic Health, Environmental and Occupational Health: 2 works · 7.5% of their workPathology and Forensic Medicine: 1 works · 4.5% of their workEverything else: 9 works · 26.7% of their workPhysical Sciences: 2 works · 6.0% of their workEngineering: 2 works · 6.0% of their workBiomedical Engineering: 2 works · 6.0% of their workSocial Sciences: 2 works · 6.0% of their workBusiness, Management and Accounting: 2 works · 6.0% of their workManagement of Technology and Innovation: 2 works · 6.0% of their workTHEIR WORKRené RiveroJiménez32works
Physical Sciences6%Health Sciences61%Social Sciences6%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine2061.3%
  2. Everything else926.7%
    1. Engineering26.0%
    1. Business, Management and Accounting26.0%
  1. 1Genetics25% of their works
  2. 2Hematology24% of their works
  3. 3Public Health, Environmental and Occupational Health8% of their works
  4. 4Management of Technology and Innovation6% of their works
  5. 5Biomedical Engineering6% of their works
  6. 6Pathology and Forensic Medicine4% of their works

Research topics

Which keywords describe René Rivero Jiménez's research?

The keywords of their largest research topics: Prognostic Factors, Rituximab, Chronic Lymphocytic Leukemia, Genomic Aberrations, Thrombosis, Acute Myeloid Leukemia, AML and Sickle-cell Disease.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 19 words, with their numbers
  1. Prognostic Factors152 topics
  2. Rituximab122 topics
  3. Chronic Lymphocytic Leukemia91 topic
  4. Genomic Aberrations91 topic
  5. Thrombosis72 topics
  6. AML61 topic
  7. Acute Myeloid Leukemia61 topic
  8. Sickle-cell Disease51 topic
  9. Thalassemia51 topic
  10. Blood Donation41 topic
  11. Extracorporeal Membrane Oxygenation41 topic
  12. Left Ventricular Assist Device41 topic
  13. Supply Chain Management41 topic
  14. Classification31 topic
  15. Factor VIII31 topic
  16. Hemophilia31 topic
  17. Immune Thrombocytopenic Purpura31 topic
  18. Lymphoma31 topic
  19. Platelets31 topic

Where does René Rivero Jiménez work?

René Rivero Jiménez's main affiliation in the publication record is Instituto de Hematología e Inmunología, Cuba.

How many publications and citations does René Rivero Jiménez have?

OpenAlex counts 32 works and 24 citations for René Rivero Jiménez, an h-index of 3, ranking #7,397,610 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about René Rivero Jiménez. Posts are plain text and can be reported.